Affidea (PRIVATE.AFFIDEA)

Overall impact
C (51)

Commentary

Affidea is an average overall performer. With a 'C' rating of 51.1 for overall impact (45th percentile compared to all companies), Affidea ranks 191st out of 277 industry peers, behind Cerba Healthcare, Allied Physicians Group, Cano Health and 187 others, and ahead of GenesisCare, Southern Veterinary Partners, Eyesouth Partners and 83 others. On top material causes for Affidea's industry (Health Care Providers & Services), Affidea performs well in Disease Eradication (96.2 score), Access to Affordable Healthcare (81.2), Disease Eradication (96.2) and 3 other causes where it received an 'A' score and performs poorly in Equal Pay and Opportunity (0.0 score), Technology Innovation (35.6), Child and Maternal Health (21.9) and 43 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.AFFIDEA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1991
Employees
15,000
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
Holland, Netherlands
Share classes
PRIVATE.AFFIDEA
More info
Description
Provider of medical diagnostic services serving private health insurers, patients, doctors, and NHS (National Health Service) across Europe. The company offers advanced diagnostic imaging, and outpatient and cancer care services. It provides advanced diagnostics, out-of-hospital services, medical imaging services, and Centres of Excellence, ensuring patients receive cost-effective and timely access to appropriate and personalized care from medical experts.
Material causes
Ethos considers the following causes material for Affidea, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.